The following are selected chemical industry transactions and financings that were executed by senior members of the Firm.

  • American Cyanamid: Acted as advisor to American Cyanamid in the divestiture of the Canadian-based Carbide Products businesses to SKW and Carbon Graphite Group.
  • American Securities: Acted as advisor to American Securities in its acquisition of a controlling interest in Arizona Chemical from Rhône Capital.
  • Apollo Global Management: Acted as advisor to Apollo in its acquisition of Taminco from CVC Capital Partners for $1.5 billion.
  • ARCO Chemical: Acted as advisor to ARCO Chemical in its acquisition of ADI/TDI assets from Olin Corporation.
  • Aristech Corporation: Acted as financial advisor to the company in evaluating shareholder value and financing alternatives.
  • Ausimont N.V.: Acted as advisor in the swap of Ausimont’s Organic Peroxide operations in Italy for Elf Atochem’s PVDF operations in Thorofare, N.J.
  • Ausimont N.V.: Acted as advisor in the sale of Ausimont’s 50% interest in its Italian Tetraethyl Lead joint venture with Great Lakes (Octel).
  • BASF AG: Acted as advisor to BASF in the sale of its North American polystyrene business to Ineos.
  • Bayer AG: Acted as advisor to Bayer Corporation in the sale of ChemDesign Corporation, a fine chemical company, to Chestnut Investments LLC.
  • BF Goodrich: Acted as advisor to BF Goodrich in the sale of its chemicals division (Noveon) to AEA Investors for $1.4 billion.
  • Borden Chemical: Acted as advisor to KKR in the sale of Borden Chemical to Apollo Management for $1.2 billion.
  • Cambrex Corp.: Bookrunner for $70 million common stock offering to fund its acquisition of Nobel Profarmaco assets.
  • Celanese AG: Acted as advisor to Celanese AG in the sale of its Worldwide Nylon 6,6 business to BASF
  • Celanese AG: Acted as advisor to Celanese AG in the sale of its Nylon 6 business to Resinas T.B., S.A. de C.V.
  • Celanese Corp.: Bookrunner for $1.04 billion IPO of Celanese Corporation.
  • Celanese Corp.: Global Coordinator on $4.2 billion bank and high yield financing for the LBO of Celanese by Blackstone.
  • CF Industries: Bookrunner for $760 million IPO of CF Industries.
  • Chemtech Industries: Acted as advisor to Chemtech Industries in the sale of its Chemical Distribution Division to Soco.
  • Chirex: Co-managed the $87 million IPO of this pharmaceutical and intermediates company.
  • CMC Materials: Completed a corporate business and financial strategy review of the company, including the consideration of strategic, growth and shareholder value enhancing alternatives.
  • Crompton Corp.: Acted as advisor to Crompton in the $2.5 billion acquisition of Great Lakes Chemical to form Chemtura.
  • Degussa AG: Acted as advisor to Degussa in the sale of its Cyanuric Chloride and Sodium Dicyanamide Businesses in Münchsmünster, Germany to Oxon Italia.
  • Deltech Corporation: Advised the shareholders of this private chemical company in its sale, in a recapitalization to management.
  • Domtar: Acted as advisor in the sale of Domtar’s Miranol surfactants business to Rhone Poulenc.
  • Domtar: Acted as advisor in the sale of Domtar’s Longford surfactants operations to Stepan.
  • Domtar: Acted as advisor in the sale of Domtar’s 50% coal tar joint venture interest to the joint venture partner, Rütgers.
  • Dow Chemical: Acted as advisor to Dow Chemical in the sale of its 50% stake in UOP LLC to Honeywell.
  • Dow Chemical: Managed a $553 million Equipment Trust Financing for Dow Chemical (Canada).
  • Dow Reichhold Specialty Latex: Acted as advisor to Dow Reichhold Specialty Latex in the sale of its Dipping Synthetic Latex business to Bangkok Synthetic Ltd.
  • Dow Reichhold Specialty Latex: Acted as advisor to Dow Reichhold Specialty Latex in the sale of its Non-Dipping Synthetic Latex business to Mallard Creek Polymers Inc.
  • DSM: Acted as advisor to DSM in the sale of its Styrene-Butadiene Resin business to Lion Chemical Capital.
  • Elemica B2B Exchange: Acted as advisor to the 8 founding companies with regard to the formation of the Elemica B2B exchange.
  • Engelhard Corp.: Bookrunner on $546 million secondary common stock offering for Engelhard.
  • Genomatica: Prepared a valuation of Genomatica for use by the board of directors and to support its equity financing
  • Genomatica: Advised Genomatica with regard to its strategy and its financial/shareholder value alternatives.
  • Genzyme Corporation: Acted as advisor to Genzyme Corporation in the sale of its Genzyme Pharmaceutical Ingredients Business in Switzerland to International Chemical Investors Group (ICIG).
  • Georgia Gulf: Co-manager of the $190 million offering of common shares.
  • Great Lakes Chemical: Acted as advisor to Great Lakes in the sale of its oilfield services business OSCA to BJ Services for $440 million.
  • Henkel: Acted as advisor to Henkel in the sale of its North American Paper Chemicals and Construction and Process Chemicals Business to Geo Specialty Chemicals.
  • INDSPEC Chemical: Acted as advisor to Castle Harlan in its sale of INDSPEC to Occidental Petroleum for $300 million.
  • International Specialty Products: Co-managed the $301 million IPO for this leading specialty chemical company.
  • Kraton Polymers: Acted as advisor to Ripplewood Holdings in the sale of Kraton Polymers to Texas Pacific Group for $770 million.
  • Lyondell Chemical: Acted as advisor to Lyondell in the acquisition of PDVSA’s 41.25% stake in Lyondell for $2.2 billion.
  • Lyondell Chemical: Manager for $765MM common stock offering to fund a portion of its acquisition of ARCO Chemical.
  • Lilly Industries: Acted as financial advisor to the company and evaluated the company’s shareholder value and alternatives.
  • Mitsubishi Corporation: Acted as advisor to Mitsubishi in its sale of Aristech Chemicals to Sunoco for $860 million.
  • Mitsubishi Group: Prepared valuation of Aristech for the Mitsubishi Group for shareholder purposes.
  • Mitsui: Advised Mitsui in the acquisition of Ocelot Ammonia in Canada from Methanex and Devco for approximately $100 million.
  • Monsanto: Acted as advisor on the sale of Monsanto’s Maleic Anhydride business to Huntsman Chemical.
  • Nippon Sanso: Acted as advisor to Nippon Sanso in its acquisition of Hercules’ Semi-Gas business.
  • NL Industries: Represented the Special Independent Committee of the Board in evaluating the proposal by Valhi Corporation to purchase the minority public shares that Valhi did not own. Offer was deemed to be unfair and was withdrawn.
  • NL Industries: Acted as advisor in the sale of Spencer Kellogg, a specialty resins business, to Reichhold for $86 million.
  • Olin Corporation: Co-managed a $101 million offering of common stock.
  • OM Group: Lead-managed the $154 million IPO of this specialty chemical comapny.
  • ÖMV: Acted as advisor in the sale of ÖMV’s Pyridate Herbicide business, Argolinz, to Sandoz.
  • ÖMV: Acted as advisor in the sale of ÖMV’s fine chemical division, Chemie Linz, located in Austria, to DSM for 2.2 billion schillings
  • Oxiteno S/A: Acted as advisor to Oxiteno S/A Indústria e Comércio , a member of the Ultra Group in Brazil, in its acquisition of Canamex Especialidades Quimicas S.A. de C.V. in Mexico.
  • PCR Group: Acted as advisor to the shareholders of PCR Group in the sale of this Organosilane company to Harris Specialty Chemicals.
  • Perkin-Elmer Corporation: Acted as advisor to the Perkin-Elmer Corporation in the sale of PerSeptive Biosystems GmbH-Hamburg to a subsidiary of SKW Trostberg AG.
  • Philipp Brothers Chemicals, Inc.: Acted as advisor to Phibro-Tech, Inc. subsidiary in the sale of Agtrol International, a fungicide and plant growth regulator business, to Nufarm Limited.
  • Phyto-Source L.P.: Advised the shareholders of Phyto-Source, a leading supplier of phytosterols, in the sale of the business to Cognis.
  • PureTec Corporation: Acted as financial advisor to the company in evaluating its shareholder value and financing alternatives.
  • Reichhold, Inc.: Advised Reichhold in the sale of its 50% interests in Synthomer Ltd. and Synthomer GmbH to Yule Catto for $95 million.
  • Reichhold, Inc.: Advised Reichhold in the sale of the Dow Legacy Synthetic Latex Business by its joint venture entity Dow Reichhold Synthetic Latex LLC to Dow Chemical Company.
  • Reichhold, Inc.: Acted as financial advisor to the company in evaluating its shareholder value and financing alternatives.
  • Reilly Industries, Inc.: Completed a number of strategic and financial advisory projects for the company and its shareholders to review its business portfolio and shareholder value/liquidity alternatives.
  • Resolution Performance Products: Acted as advisor to Shell Chemicals in the sale of its Global Resins and Versatics business to Apollo Management for $860 million.
  • Rexene Corporation: Acted as advisor to the holders of $401 million of principal amount of Senior and Senior Subordinated Notes in a successful prepackaged bankruptcy.
  • Rhone-Poulenc: Acted as advisor to Rhone-Poulenc in the sale/transfer of its TDI business to ARCO Chemical.
  • Rustoleum: Acted as advisor to the shareholders of Rustoleum in its sale to RPM Corporation for $183 million.
  • Shell: Acted as advisor to Shell Chemical in the sale of it polypropylene and related catalyst operations to Union Carbide. Sale was required by the anti-trust authorities to allow the merger of the remaining Shell and Himont Polypropylene operations.
  • Shell: Acted as advisor to Shell Chemicals in the sale of its KRATON Polymers business to Ripplewood for $560MM.
  • Solenis: Completed diversification corporate strategy review with recommended M&A and growth alternatives.
  • Solutia: Acted as advisor to Solutia in the sale of its Scripset Polymer Resins business to Hercules Incorporated.
  • Sterling Chemicals, Inc.: Acted as financial advisor to the company in evaluating its shareholder value and financing alternatives.
  • Sterling Chemicals, Inc.: Acted as advisor to the company in the sale of its styrene capacity rights to Nova Chemicals.
  • Sybron Chemicals: Acted as advisor to Sybron Chemical in its acquisition of the Textile Chemical operations of National Starch, a division of Unilever.
  • Synthon Chiragenics: Acted as advisor to Synthon Chiragenics in the sale of its Fine Chemicals business and the license of certain technology rights to Avecia Ltd.
  • TETRA Technologies: Acted as financial advisor to the company in evaluating shareholder value and financing alternatives.
  • Thai Petrochemical: Co-manager of the company’s initial public offering of common stock. Total offering was $146 million.
  • TransCanada Pipeline: Acted as advisor to the company in the sale of ANGUS Chemical to Dow Chemical for $400 million.
  • Ultrapar Participacoes SA (Grupo Ultra): Bookrunner on the $202 million IPO of Grupo Ultra.
  • Undisclosed Client: Sale of a substantial interest in a Brazilian chemical company to another Brazilian chemical company.
  • Union Carbide Corp.: Bookrunner for $200 million issuance of 100 year debt.
  • Uniroyal Chemical: Acted as advisor to Uniroyal Chemical in its $1.4 billion merger with Crompton & Knowles Corp.
  • Wellman: Acted as advisor to Wellman in it acquisition of Akzo Nobel’s PET bottle resin operations in the Netherlands.